CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Immucor, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Immucor, Inc.
3130 Gtwy
PO Box 5625
Phone: (770) 441-2051p:770 441-2051 NORCROSS, GA  30091-5625  United States Fax: (770) 441-3807f:770 441-3807

This company was Merged or Acquired on 3/15/2023.
This company ceased filing statements with the SEC on 7/25/2017.
This is a Subsidiary, click here for the Parent Company

Business Summary
Immucor, Inc. is a United States-based company, which develops, manufactures and sells transfusion and transplantation diagnostics products. The Company operates through two segments: Transfusion and Transplant & Molecular. Its products are used in determining compatibility between a patient and a donor for the purposes of a blood transfusion, organ or stem cells transplant. It offers transfusion diagnostics, such as serology reagents, and instruments, such as NEO, Echo and Capture Workstation. It offers transplant and molecular diagnostics, which includes its molecular products. It offers human erythrocyte antigen and Human Platelet Antigen assays, as well as semi-automated molecular immunohematology instrument, the Array Imaging System and BASIS database. It offers human leukocyte antigen (HLA)-related testing products, such as serological typing trays, and also sells assays that monitor organ health post-transplant. It also offers platelet-focused products.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
--YesYesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Jeffrey R.Binder 53 1/1/2015 1/1/2015
Chief Financial Officer and Vice President, International Transfusion Diagnostics DominiquePetitgenet 54 1/1/2015
Lead Director William A.Hawkins 62 10/1/2011 10/1/2011
4 additional Officers and Directors records available in full report.

Business Names
Business Name
BioArray Solutions Limited
Dominion Biologicals Limited
GTI Diagnostics GmbH
17 additional Business Names available in full report.

General Information
Number of Employees: 1,050 (As of 5/31/2013)
Outstanding Shares: 100 (As of 4/11/2017)
Shareholders: 405
Stock Exchange: NASD
Federal Tax Id: 222408354
Fax Number: (770) 441-3807
Email Address: cvinson@immucor.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024